Jens V. Kringelum

Dr Neergaards Vej 5F
Horsholm, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.

Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.

Journal: NPJ vaccines
Published: October 03, 2024

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Journal: Journal for immunotherapy of cancer
Published: May 01, 2024

An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens.

An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens.

Journal: Nature communications
Published: February 26, 2024

Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes.

Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes.

Journal: Nature communications
Published: November 05, 2023

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Journal: Frontiers in immunology
Published: September 07, 2023

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Journal: Frontiers in immunology
Published: June 05, 2023

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.

Journal: Oncoimmunology
Published: January 17, 2022

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design.

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design.

Journal: Nature communications
Published: March 27, 2020

Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.

Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.

Journal: Immunogenetics
Published: April 12, 2019

Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.

Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.

Journal: Immunology
Published: January 02, 2018

High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays.

High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays.

Journal: Scientific reports
Published: August 01, 2016

Improved pan-specific prediction of MHC class I peptide binding using a novel receptor clustering data partitioning strategy.

Improved pan-specific prediction of MHC class I peptide binding using a novel receptor clustering data partitioning strategy.

Journal: HLA
Published: March 05, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026